Qiaoli L. Lv
Jiangxi Key Laboratory Of Oncology, P.R. China
Nanchang, 330029, China
Nanchang, 330029, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 22 publications
MiR-424 induce buffalo (Bubalus bubalis) follicular atresia via targeting and inhibiting SERPINB2.
Journal: Animal reproduction science
Published: May 24, 2026
RBM43 promotes glioma aggressiveness and shapes the immune microenvironment through macrophage polarization.
Journal: Discover oncology
Published: February 04, 2026
The Wnt signaling pathway plays a key role in regulating the pluripotent state of rbESCs and promoting their commitment to the primordial germ cell fate.
Journal: Cellular signalling
Published: November 17, 2025
Microfluidic fabrication of peptide modified carrier-free self-assembled crizotinib-metal nanodrugs for NIR fluorescence imaging and dual-pathway therapy of non-small cell lung cancer.
Journal: Journal of colloid and interface science
Published: October 23, 2025
ATR inhibitors: from targeting the DNA damage response to exploiting synthetic lethality-A paradigm shift in Cancer therapy.
Journal: Bioorganic chemistry
Published: September 11, 2025
Targeting serine synthesis pathway to reverse paclitaxel resistance in NSCLC with combination of paclitaxel and anlotinib.
Journal: Journal of experimental & clinical cancer research : CR
Published: September 07, 2025
NAT10 and ac4C modification in cancer immunity and metabolism: emerging mechanisms and therapeutic potential.
Journal: Journal of translational medicine
Published: July 30, 2025
GPER in metabolic homeostasis and disease: molecular mechanisms, nutritional regulation, and therapeutic potential.
Journal: Journal of translational medicine
Published: May 31, 2025
Primordial follicle activation related genes screening and differential expressed analysis by transcriptome sequencing in buffalo ovary after PI3K and mTOR stimulators activated.
Journal: Animal biotechnology
Published: May 28, 2025
HNRNPH1 stabilizes FLOT2 mRNA in a non-canonical m6A-dependent manner to promote malignant progression in nasopharyngeal carcinoma.
Journal: Cellular oncology (Dordrecht, Netherlands)
Published: November 11, 2024
Research progress and development strategy of PI3K inhibitors for breast cancer treatment: A review (2016-present).
Journal: Bioorganic chemistry
Published: September 05, 2024
Last Updated: 09/26/2026